Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago-area babies developed a dangerous intestinal disease after consuming the company’s formula for premature ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of products beyond that and an overall diversified healthcare ...

Abbott Laboratories ABT0.85%increase; green up pointing triangle cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected flu season hurt its recent ...

Abbott Laboratories (NYSE: ABT) more or less met analyst estimates in its first quarter, the results of which were published early Thursday morning. This clearly wasn't good enough for investors, as ...

This call is being recorded by Abbott. With the exception of any participant's questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is ...

Investors had more of an issue with guidance. The company cut its full-year forecast for adjusted profitability. In the quarter, Abbott's sales totaled just under $11.2 billion, nearly 8% higher year ...

Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said its nutrition unit continued to notch soft sales during the first quarter. The company, which sells ...

Abbott Laboratories (ABT) and exchange traded funds with significant exposure to the healthcare company drew investor attention Thursday after the stock declined 4.5% following its latest earnings ...